| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 1,019.93 | 99.46 | 19.70p | 10.6 | 0.4 | +24% | 11.66p | 0.0% |
| 31-Dec-27 | 1,054.35 | 111.57 | 23.24p | 9.0 | 0.5 | +18% | 11.94p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Current | 1 week ago | 1 month ago | 3 months ago | 6 months ago | 1 year ago | |
|---|---|---|---|---|---|---|
| Revenue (£m) | ||||||
| 31-Dec-2026 | n/a | n/a | 1,020 | 1,020 | 1,034 | n/a |
| 31-Dec-2027 | n/a | n/a | 1,054 | 1,054 | 1,071 | n/a |
| Earnings | ||||||
| 31-Dec-2026 | n/a | n/a | 19.70p | 19.70p | 22.49p | n/a |
| 31-Dec-2027 | n/a | n/a | 23.24p | 23.24p | 25.84p | n/a |
| Dividend | ||||||
| 31-Dec-2026 | n/a | n/a | 11.66p | 11.66p | 11.82p | n/a |
| 31-Dec-2027 | n/a | n/a | 11.94p | 11.94p | 12.01p | n/a |
| Recommendations | ||||||
| Strong Buy | 0 | 0 | 0 | 5 | 0 | 0 |
| Buy | 0 | 0 | 2 | 2 | 0 | 0 |
| Neutral | 0 | 0 | 0 | 3 | 0 | 0 |
| Sell | 0 | 0 | 0 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Brokers | 0 | 0 | 2 | 11 | 0 | 0 |
| Average Rec | n/a | n/a | 7.50 | 7.50 | n/a | n/a |
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds |
| Share Price | 215.00p |
| Change Today | 5.50p |
| % Change | 2.63 % |
| 52 Week High | 243.50 |
| 52 Week Low | 182.00 |
| Volume | 869,438 |
| Shares Issued | 276.68m |
| Market Cap | £594.85m |
| Beta | 0.00 |
| Value | ![]() |
|---|
| Price Trend | ![]() |
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 5 |
| Buy | 2 |
| Neutral | 3 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 11 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 09-Apr-26 | 23-Oct-25 |
| Paid | 12-May-26 | 17-Nov-25 |
| Amount | 6.80p | 5.40p |
| Time | Volume / Share Price |
| 14:59 | 45 @ 215.00p |
| 16:35 | 677 @ 215.00p |
| 16:35 | 2,504 @ 215.00p |
| 16:35 | 2,404 @ 215.00p |
| 16:35 | 777 @ 215.00p |
| CFO | Richard Armitage |
| CEO | Damien Caby |
You are here: research